Vancouver BC, Toronto ON, and Montreal QC – adMare BioInnovations (adMare) is pleased to welcome twenty emerging leaders to Cohort VIII of the Executive Institute, its flagship leadership program designed to… Read More
CDA issues positive reimbursement recommendation for QALSODY INESSS recognizes QALSODY’s promising clinical value and highlights path toward reimbursement HTA assessments highlight importance of timely and equitable access to QALSODY for… Read More
Novartis applauds Ontario’s bold leadership in launching the FAST program, which accelerates access to breakthrough therapies like Scemblix® for patients living with cancer. Scemblix® (asciminib) was recently approved for newly diagnosed and… Read More
Ease, speed and safety of IPCOAT™ liquid adhesion barrier device application demonstrated during gynecologic endometriosis surgery VANCOUVER, BC – ARC Medical Inc. (“ARC”), a leader in surgical adhesion prevention innovation, announced the… Read More
New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to the marked reduction in blood pressure in a high-risk CKD population with… Read More
